- Home
- / Sunshine Guojian Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Sunshine Guojian Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥23.8
2024-10-29
Market Capitalization
¥14.4 B
2024-10-29
Revenue
¥4.2 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.1B | 1.2B | 650.4M | 924.0M | 811.7M | 995.5M | 1.2B | 4.2B |
| Cost of goods sold | 118.3M | 146.0M | 102.3M | 210.0M | 201.2M | 224.1M | 304.3M | 333.0M |
| Gross profit | 1.0B | 1.0B | 549.5M | 714.7M | 618.1M | 780.6M | 879.9M | 3.9B |
| Gross profit margin, % | 88.6% | 84.5% | 77.3% | 76.1% | 78.4% | 75.2% | 92.5% | |
| Operating expense total | 668.4M | 861.5M | 681.0M | 683.4M | 508.6M | 464.7M | 939.6M | 663.9M |
| Depreciation and amortization | 136.0M | 135.5M | 122.4M | 116.1M | 129.4M | 147.1M | ||
| EBITDA | 351.5M | 166.1M | (141.2M) | 27.9M | 94.0M | 299.4M | 336.2M | 3.3B |
| EBITDA margin, % | 14.3% | -21.7% | 3.0% | 11.6% | 30.1% | 28.7% | 78.4% | |
| EBIT | 376.7M | 194.6M | (281.7M) | (73.1M) | 22.5M | 288.0M | 260.7M | 3.2B |
| EBIT margin, % | 16.8% | -43.3% | -7.9% | 2.8% | 28.9% | 22.3% | 76.8% | |
| Interest income | 33.1M | 30.8M | 14.6M | 20.0M | 39.6M | 55.8M | 84.3M | |
| Interest expense | (23.9M) | 1.3M | 1.4M | 1.2M | 569.0K | |||
| Pre tax profit | 411.3M | 229.2M | (282.4M) | (53.4M) | 29.0M | 310.6M | 707.7M | 3.3B |
| Income tax expense | 53.4M | 19.2M | (46.6M) | (51.7M) | (16.5M) | 27.3M | 16.3M | 426.7M |
| Net Income | 358.0M | 210.0M | (235.8M) | (1.7M) | 45.4M | 283.4M | 691.4M | 2.9B |